Actively Recruiting
Molecular Biology of Polycythemia and Thrombocytosis
Led by University of Utah · Updated on 2026-03-09
200
Participants Needed
1
Research Sites
1148 weeks
Total Duration
On this page
Sponsors
U
University of Utah
Lead Sponsor
N
National Heart, Lung, and Blood Institute (NHLBI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Our study is designed to characterize the clinical picture and genetic pattern of Polycythemia and Thrombocytosis. The purpose of this project is to find a gene and its mutation that causes these disorders. When this is accomplished, new therapies to control and eventually cure the disorder can be designed.
CONDITIONS
Official Title
Molecular Biology of Polycythemia and Thrombocytosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Subjects with an elevated hemoglobin concentration (>18 in males and >16 in females)
- Subjects with an elevated platelet count (>450,000)
You will not qualify if you...
- Subjects who have a known acquired cause of polycythemia and thrombocytosis
- Subjects with heart disease, left to right heart shunt or severe pulmonary disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Utah
Salt Lake City, Utah, United States, 84132
Actively Recruiting
Research Team
J
Josef T Prchal, MD
CONTACT
S
Soo Jin Kim, MS
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here